Jacqualyn A. Fouse
2015 - Celgene
In 2015, Jacqualyn A. Fouse earned a total compensation of $8.1M as President Hematology and Oncology at Celgene, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,679,323 |
|---|---|
| Option Awards | $1,405,470 |
| Salary | $845,667 |
| Stock Awards | $2,124,401 |
| Other | $18,641 |
| Total | $8,073,502 |
Fouse received $3.7M in non-equity incentive plan, accounting for 46% of the total pay in 2015.
Fouse also received $1.4M in option awards, $845.7K in salary, $2.1M in stock awards and $18.6K in other compensation.
Rankings
In 2015, Jacqualyn A. Fouse's compensation ranked 769th out of 13,638 executives tracked by ExecPay. In other words, Fouse earned more than 94.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 769 out of 13,638 | 94th |
Division Manufacturing | 273 out of 5,190 | 95th |
Major group Chemicals And Allied Products | 96 out of 1,854 | 95th |
Industry group Drugs | 75 out of 1,528 | 95th |
Industry Pharmaceutical Preparations | 60 out of 1,182 | 95th |
Source: SEC filing on April 28, 2016.
Fouse's colleagues
We found five more compensation records of executives who worked with Jacqualyn A. Fouse at Celgene in 2015.